ArticleBMC pharmacology & toxicology2025

Characteristics, risk factors and a risk prediction model of tocilizumab-induced hypofibrinogenemia: a retrospective real-world study of inpatients.

Le Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.